171 related articles for article (PubMed ID: 17655511)
1. Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study.
Schroeder JR; Schmittner J; Bleiberg J; Epstein DH; Krantz MJ; Preston KL
Pharmacotherapy; 2007 Aug; 27(8):1111-9. PubMed ID: 17655511
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.
Schmittner J; Schroeder JR; Epstein DH; Krantz MJ; Eid NC; Preston KL
Pharmacotherapy; 2009 May; 29(5):495-502. PubMed ID: 19397459
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
Walsh SL; Strain EC; Bigelow GE
Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
[TBL] [Abstract][Full Text] [Related]
4. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
[TBL] [Abstract][Full Text] [Related]
5. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
[TBL] [Abstract][Full Text] [Related]
6. Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
Beswick T; Best D; Rees S; Bearn J; Gossop M; Strang J
Addict Biol; 2003 Mar; 8(1):49-57. PubMed ID: 12745416
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Buntwal N; Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
[TBL] [Abstract][Full Text] [Related]
8. Management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
[No Abstract] [Full Text] [Related]
9. Expanded table: Some drugs for management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
[No Abstract] [Full Text] [Related]
10. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal.
Lin SK; Strang J; Su LW; Tsai CJ; Hu WH
Drug Alcohol Depend; 1997 Nov; 48(2):127-33. PubMed ID: 9363412
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.
Fishman M; Tirado C; Alam D; Gullo K; Clinch T; Gorodetzky CW;
J Addict Med; 2019; 13(3):169-176. PubMed ID: 30531234
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
[TBL] [Abstract][Full Text] [Related]
14. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
Carnwath T; Hardman J
Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
[TBL] [Abstract][Full Text] [Related]
15. Lofexidine (Lucemyra) for opioid withdrawal.
Med Lett Drugs Ther; 2018 Jul; 60(1551):115-117. PubMed ID: 30036346
[No Abstract] [Full Text] [Related]
16. Unexpected delirium during Rapid Opioid Detoxification (ROD).
Golden SA; Sakhrani DL
J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
[TBL] [Abstract][Full Text] [Related]
17. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
Gish EC; Miller JL; Honey BL; Johnson PN
Ann Pharmacother; 2010 Feb; 44(2):343-51. PubMed ID: 20040696
[TBL] [Abstract][Full Text] [Related]
18. A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
Gorodetzky CW; Walsh SL; Martin PR; Saxon AJ; Gullo KL; Biswas K
Drug Alcohol Depend; 2017 Jul; 176():79-88. PubMed ID: 28527421
[TBL] [Abstract][Full Text] [Related]
19. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
Kahn A; Mumford JP; Rogers GA; Beckford H
Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
[TBL] [Abstract][Full Text] [Related]
20. Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal.
Darpö B; Pirner M; Longstreth J; Ferber G
Drug Alcohol Depend; 2019 Dec; 205():107596. PubMed ID: 31606589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
